CClassifation of CannabisPublic classificationby Justin Strekal, NORML Political Director
October 16, 2018
Comments
The US Food and Drug Administration is seeking public comments specific to whether changes ought to be recommended regarding the international classification of cannabis as a controlled substance. Members of the public have until October 31, 2018 to submit their comments to the FDA for consideration.
The FDA says that the comments “will be considered in preparing a response from the United States to the World Health Organization regarding the abuse liability and diversion” of marijuana and certain other substances.
In April, in response to a similar FDA request, NORML collected and hand-delivered over 10,000 comments to the agency calling on it to recommend a lifting of international restrictions criminalizing the plant. In total, comments from NORML members totaled over 60% of the public comments submitted nationwide.
Click here to submit a public comment NOW
In NORML’s latest comments to the FDA, it opined that “cannabis be removed from the international drug conventions so that nations that wish to do so may further expand their regulations governing cannabis’ use, possession, production, and dispensing for either recreational or medical use.”
Let’s continue to dominate the debate. Click here to submit your own public comment now.
Then take the next step:
Share our Action Alert on Twitter
Share our Action Alert on Facebook
Posted in : ACTIVISM, Advocacy, Citizen Lobbyists, GOVERNMENT, Policy
Add Your Comment
Do your part to
help legalize marijuana! (how?)
Act!
Donate
Lawyers
Shop
NORML Newsletter
FDA Seeks Public Comments Regarding International Classification Of Cannabis
October 17, 2018
CClassifation of CannabisPublic classificationby Justin Strekal, NORML Political Director
October 16, 2018
Comments
The US Food and Drug Administration is seeking public comments specific to whether changes ought to be recommended regarding the international classification of cannabis as a controlled substance. Members of the public have until October 31, 2018 to submit their comments to the FDA for consideration.
The FDA says that the comments “will be considered in preparing a response from the United States to the World Health Organization regarding the abuse liability and diversion” of marijuana and certain other substances.
In April, in response to a similar FDA request, NORML collected and hand-delivered over 10,000 comments to the agency calling on it to recommend a lifting of international restrictions criminalizing the plant. In total, comments from NORML members totaled over 60% of the public comments submitted nationwide.
Click here to submit a public comment NOW
In NORML’s latest comments to the FDA, it opined that “cannabis be removed from the international drug conventions so that nations that wish to do so may further expand their regulations governing cannabis’ use, possession, production, and dispensing for either recreational or medical use.”
Let’s continue to dominate the debate. Click here to submit your own public comment now.
Then take the next step:
Share our Action Alert on Twitter
Share our Action Alert on Facebook
Posted in : ACTIVISM, Advocacy, Citizen Lobbyists, GOVERNMENT, Policy
Add Your Comment
Do your part to
help legalize marijuana! (how?)
Act!
Donate
Lawyers
Shop
NORML Newsletter
Search
RECENT PRESS RELEASES
Home Values To Plunge in ‘Climate Abandonment’ Zones—Here’s Where To Buy Instead
SWI Editorial StaffFebruary 10, 2025|
Climate Pollutant Phasedown Plan Carries Unresolved PFAS Risk
SWI Editorial StaffFebruary 10, 2025|
A former EPA assistant administrator US environmental policy in the age of Musk and Trump
SWI Editorial StaffFebruary 10, 2025|
Environmental groups urge AI industry to reduce emissions
SWI Editorial StaffFebruary 10, 2025|
The AI investment frenzy, charted
SWI Editorial StaffFebruary 10, 2025|
Mirova fund gets backing from institutional investors and DFIs
SWI Editorial StaffFebruary 10, 2025|
Related Post
Livewire Ergogenics, Inc. Updates OTC Filing Status
The Energy Tech Gap Between Solar and Oil & Gas
Bitcoin Price Edges Higher But Remains Stuck In a Tight Zone
Bitcoin’s Price Action ‘Looks Very Manufactured’—Samson Mow Questions Market Dynamics Amid Institutional Inflows